An orally bioavailable small molecule, belonging to the class of c-Met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors, with potential … [Read more...]
M
Met tyrosine kinase inhibitor BMS-777607
An inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or hepatocyte … [Read more...]
MET tyrosine kinase inhibitor EMD 1214063
An inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor EMD 1214063 selectively binds to MET tyrosine kinase … [Read more...]
MET tyrosine kinase inhibitor PF-02341066
A substance being studied in the treatment of some types of cancer. It blocks enzymes that cancer cells need to grow and spread. It may also prevent the growth … [Read more...]
MET tyrosine kinase inhibitor PF-04217903
An orally bioavailabe, small-molecule tyrosine kinase inhibitor with potential antineoplastic activity. MET tyrosine kinase inhibitor PF-04217903 selectively … [Read more...]
MET/VEGFR-2 inhibitor GSK1363089
A substance being studied in the treatment of cancer. MET/VEGFR-2 inhibitor GSK1363089 blocks enzymes involved in the growth and spread of tumor cells. It may … [Read more...]
metabolic
Having to do with metabolism (the total of all chemical changes that take place in a cell or an organism to produce energy and basic materials needed for … [Read more...]
metabolic acidosis
A condition in which the blood is too acidic. It may be caused by severe illness or sepsis (bacteria in the bloodstream). … [Read more...]
metabolic disorder
A condition in which normal metabolic processes are disrupted, usually because of a missing enzyme. … [Read more...]
metabolic syndrome
A condition is marked by extra fat around the abdomen, high levels of blood glucose (sugar) when not eating, high levels of triglycerides (a type of fat) in the … [Read more...]